Philadelphia Chromosome-like Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Philadelphia Chromosome-like Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-15Clinical Trial Update: A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
A Phase 1/Phase 2 study evaluating ponatinib with chemotherapy in children, teenagers, and adults with Philadelphia chromosome–positive ALL,…
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia [Phase 2]
A Phase 2 trial evaluating ruxolitinib phosphate or dasatinib with chemotherapy in relapsed or refractory Philadelphia chromosome-like acute…